Assessment of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model in Hypoplastic Myelodysplastic Syndromes

被引：1
|
作者：
Aguirre, Luis E. [1 ]
Al Ali, Najla [2 ]
Ball, Somedeb [1 ]
Singh, Avani M. [1 ]
Jain, Akriti G. [3 ]
Chan, Onyee [1 ]
Schwabkey, Zaker, I [1 ]
Tinsley-Vance, Sara M. [1 ]
Kuykendall, Andrew [1 ]
Sweet, Kendra [1 ]
Lancet, Jeffrey E. [1 ]
Padron, Eric [1 ]
Sallman, David A. [2 ]
Komrokji, Rami S. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Wesley Chapel, FL USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-171044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6909 / 6911
页数：3
相关论文
共 50 条
  • [21] The Revised International Prognostic Scoring System "Molecular" (IPSS-Rm), a Validated and Dynamic Model in Treated Patients with Myelodysplastic Syndromes (MDS)
    Nazha, Aziz
    Narkhede, Mayur Subhash
    Radivoyevitch, Tomas
    Kalaycio, Matt
    Patel, Bhumika J.
    Gerds, Aaron T.
    Mukherjee, Sudipto
    Clemente, Michael
    Hirsch, Cassandra M.
    Advani, Anjali S.
    Przychodzen, Bartlomiej
    Carraway, Hetty E.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2015, 126 (23)
  • [22] Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)
    Germing, U
    Hildebrandt, B
    Pfeilstöcker, M
    Nösslinger, T
    Valent, P
    Fonatsch, C
    Lübbert, M
    Haase, D
    Steidl, C
    Krieger, O
    Stauder, R
    Giagounidis, AAN
    Strupp, C
    Kündgen, A
    Mueller, T
    Haas, R
    Gattermann, N
    Aul, C
    LEUKEMIA, 2005, 19 (12) : 2223 - 2231
  • [23] Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)
    U Germing
    B Hildebrandt
    M Pfeilstöcker
    T Nösslinger
    P Valent
    C Fonatsch
    M Lübbert
    D Haase
    C Steidl
    O Krieger
    R Stauder
    A A N Giagounidis
    C Strupp
    A Kündgen
    T Mueller
    R Haas
    N Gattermann
    C Aul
    Leukemia, 2005, 19 : 2223 - 2231
  • [24] APPLICATION OF THE MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS-M) MODEL IN SOUTH-AMERICAN MDS PATIENTS: A STUDY FROM ARGENTINA AND URUGUAY
    Lincango, M.
    Andreoli, V.
    Rivello, H. Garcia
    Asinari, M.
    Bender, A.
    Alfero, C.
    Catalan, A.
    Rahhal, M.
    Delamer, R.
    Osorio, M. J. Mela
    Navickas, A.
    Grille, S.
    Agriello, E.
    Castro, M.
    Perusini, M. A.
    Arbelbide, J.
    Basquiera, A.
    Belli, C.
    LEUKEMIA RESEARCH, 2023, 128
  • [25] Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index
    van Spronsen, M. F.
    Ossenkoppele, G. J.
    Holman, R.
    van de Loosdrecht, A. A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (18) : 3198 - 3205
  • [26] Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes
    Kewan, Tariq
    Bahaj, Waled
    Durmaz, Arda
    Aly, Mai
    Ogbue, Olisaemeka D.
    Carraway, Hetty E.
    Sekeres, Mikkael A.
    Visconte, Valeria
    Gurnari, Carmelo
    Maciejewski, Jaroslaw P.
    BLOOD, 2023, 141 (14) : 1768 - 1772
  • [27] CLINICIAN UTILIZATION OF THE INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS) FOR NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS
    Pease, D.
    Ross, J.
    Poynter, J.
    Nguyen, P.
    Hirsch, B.
    Cioc, A.
    Roesler, M.
    Warlick, E.
    LEUKEMIA RESEARCH, 2015, 39 : S118 - S118
  • [28] Impact Of Revised-International Prognostic Scoring System (R-IPSS) Cytogenetic-Risk Stratification In Myelodysplastic Syndrome
    Otazo, Maria
    Yellapragada, Sarvari Venkata
    Zheng, Matthew
    Li, Ang
    Perez, Ruben Hernandez
    Rivero, Gustavo A.
    BLOOD, 2013, 122 (21)
  • [29] Application of the international Prognostic Scoring System for myelodysplastic syndromes
    Maes, B
    Meeus, P
    Michaux, L
    Bijnens, L
    Boogaerts, M
    Hagemeijer, A
    De Wolf-Peeters, C
    Verhoef, G
    ANNALS OF ONCOLOGY, 1999, 10 (07) : 825 - 829
  • [30] Revised International Prognostic Scoring System for Myelodysplastic Syndromes
    Greenberg, Peter L.
    Tuechler, Heinz
    Schanz, Julie
    Sanz, Guillermo
    Garcia-Manero, Guillermo
    Sole, Francesc
    Bennett, John M.
    Bowen, David
    Fenaux, Pierre
    Dreyfus, Francois
    Kantarjian, Hagop
    Kuendgen, Andrea
    Levis, Alessandro
    Malcovati, Luca
    Cazzola, Mario
    Cermak, Jaroslav
    Fonatsch, Christa
    Le Beau, Michelle M.
    Slovak, Marilyn L.
    Krieger, Otto
    Luebbert, Michael
    Maciejewski, Jaroslaw
    Magalhaes, Silvia M. M.
    Miyazaki, Yasushi
    Pfeilstoecker, Michael
    Sekeres, Mikkael
    Sperr, Wolfgang R.
    Stauder, Reinhard
    Tauro, Sudhir
    Valent, Peter
    Vallespi, Teresa
    van de Loosdrecht, Arjan A.
    Germing, Ulrich
    Haase, Detlef
    BLOOD, 2012, 120 (12) : 2454 - 2465
12345